| Financial Year |
March 31 2023 |
| Monetary Funds |
739,004,798.75 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
93,931,211.57 |
| Advances to Suppliers |
2,667,740.79 |
| Other Receivables |
14,752,255.52 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
93,315,823.99 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
15,592,588.43 |
| Total Current Assets |
978,313,419.05 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
12,156,060.98 |
| Fixed Assetes |
376,752,798.41 |
| Under-construction Projects |
741,628.32 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
58,084,469.55 |
| R&D expenses |
17,608,797.85 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,025,245.93 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
512,914,225.69 |
| Total Assets |
1,491,227,644.74 |
| Short-Term Loans |
50,085,479.45 |
| Trading Financial liabilities |
-- |
| Notes Payable |
30,370,000.00 |
| Accounts Payable |
59,280,144.34 |
| Accounts Received In Advance |
688,899.12 |
| Employee Compensation Payable |
7,400,948.99 |
| Taxes Payable |
3,903,860.48 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
38,458,089.69 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,709,825.55 |
| Other Current Liabilities |
274,499.61 |
| Sub-Total of Current Liabilities |
194,283,282.73 |
| Long-term Loans |
-- |
| Bonds Payable |
898,147,206.02 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
89,832,376.90 |
| Deferred Income Tax Liabilities |
3,853,094.87 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
998,342,875.99 |
| Total Liabilities |
1,192,626,158.72 |
| Paid-In Capital(Or Share Stock) |
536,686,959.00 |
| Capital Surplus |
1,310,075,675.49 |
| Surplus Reserve |
60,559,514.31 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,812,292,524.88 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
298,601,486.02 |
| Owner's Equity（Stockholder's Equity） |
298,601,486.02 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,491,227,644.74 |
